Clik here to view.
Too many shorts kill the cat
We're not going to recover as a economy if there are so many shorts in the market. The whole system is now basically being run by people who are betting against the rest of us. This means that every...
View ArticleClik here to view.
Nu Skin and the short-sellers
The $2 billion multilevel marketer in Utah -- with ties to Mitt Romney -- says its skin-care and nutritional products can delay aging. But short-sellers and a couple of angry ex-husbands are taking the...
View ArticleClik here to view.
Forget the plunging stock price, here’s Valeant’s biggest problem
Valeant Pharmaceuticals’ stock price has plunged 42% over the past week, cleaving away as much as $25.36 billion in market value. That devastating loss shouldn't be the drug maker’s biggest concern,...
View ArticleClik here to view.
Valeant short seller on pharmacy alliance: It’s the ‘turd in the punch bowl’
Valeant Pharmaceutical has been embroiled in controversy for a while, first for its acquisition strategy, then because of its practice of acquiring drugs and jacking up prices. But the allegations of...
View ArticleClik here to view.
This Short Seller Has Raised $100 Million to Bet Against a Single Stock
Sahm Adrangi’s Kerrisdale Capital Management has raised approximately $100 million from investors to bet against a single stock, a person familiar with the situation told Reuters. The new Kerrisdale...
View ArticleClik here to view.
Here’s Why Alibaba’s Accounting Is As Alarming As Enron’s
Jim Chanos, the hedge fund manager who was one of the first to detect problems at Enron, says the accounting at Alibaba Group is as problematic as the now-defunct, corrupt energy company. Chanos...
View ArticleClik here to view.
Hacking Report on St. Jude Pacemakers Was Flawed, Researchers Say
A report on cybersecurity vulnerabilities in St. Jude Medical’s implantable heart devices released last week by short sellers was flawed and didn’t prove the flaws existed, according to a review by...
View Article
